Skip to main content

Table 1 Eligibility criteria

From: The Women’s Health Initiative cancer survivorship clinic incorporating electronic patient-reported outcomes: a study protocol for the Linking You to Support and Advice (LYSA) randomized controlled trial

Inclusion criteria

Exclusion criteria

• Aged 18 years or older

• Not treated with curative intent

• Diagnosed with early-stage breast or gynaecologic cancer within 12 months of completion of primary curative therapy

- Breast cancer: Stage I-III hormone receptor-positive (defined as estrogen receptor and/or progesterone receptor ≥ 1%) and HER2-negative per ASCO-CAP guidelines on or recommended to commence adjuvant endocrine therapy during the study period

- Cervical cancer: Stage I to III treated with curative intent

• Endometrial cancer: treated with curative intent adjuvant radiotherapy +/- chemotherapy

• Diagnosed with premalignant disease (e.g., Ductal Carcinoma In-Situ DCIS/Lobular Carcinoma In-Situ LCIS)

• Have access to the internet

• Persons who, in the opinion of the Principal Investigator, researcher or supervising clinician, are unable to engage adequately with the study protocol (e.g., inability to travel to the hospital site for in-person visits, unable to communicate fluently in English)

• Ability to provide written informed consent

• Recent participation (within 12 months) in a similar study or programme involving a lifestyle intervention (e.g., diet, exercise, survivorship), based on the discretion of the Principal Investigator

• Ability to read and understand English